EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSAPEG00000012461
Gene Symbol: MIF
2 Cross references
232 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSAPEG00000019008
Gene Symbol: MIF
2 Cross references
232 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSAPEG00000010890
Gene Symbol: MMP1
2 Cross references
307 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSAPEG00000005500
Gene Symbol: MMP14A
1 Cross references
199 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSAPEG00000020162
Gene Symbol: MMP14B
1 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSAPEG00000009591
Gene Symbol: MMP2
1 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSAPEG00000019893
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSAPEG00000008291
Gene Symbol: MTOR
1 Cross references
222 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSAPEG00000014793
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSAPEG00000007864
Gene Symbol: MC4R
1 Cross references
211 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSAPEG00000002388
Gene Symbol: MTNR1AA
1 Cross references
190 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSAPEG00000001592
Gene Symbol: MME
2 Cross references
236 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).